Table 2

Study characteristics

ModelHERDOO2ViennaDASH
Year of publication200820102012
CountryFour countries (unspecified)AustriaAustria, Canada, Italy, Switzerland, UK, USA
Study setting12 tertiary care centres, patients enrolled between October 2001 and March 2006Recruited from 4 thrombosis centres in Vienna between July 1992 and August 2008Patient-level meta-analysis of previously published studies (11)
Study designProspective cohort studyProspective cohort studyIndividual patient data from 7 prospective studies
Clinical outcomeRecurrent VTERecurrent VTERecurrent VTE
Key prediction time points (months)12 months12, 60 months12, 24, 60 months
Total sample size6469291818
Events91176239
  • VTE, venous thromboembolism.